Literature DB >> 23948591

On the TRAIL of obesity and diabetes.

Hanis H Harith1, Margaret J Morris, Mary M Kavurma.   

Abstract

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has been extensively studied for its preferential ability to induce apoptosis of cancer cells. Beyond the cytotoxic capacity of TRAIL, new physiological and pathological roles for TRAIL have been identified, and there is now growing evidence supporting its involvement in the development of obesity and diabetes. This review summarizes the most recent findings associating TRAIL with obesity and diabetes in both humans and experimental settings. We also present and discuss some of the reported controversies behind TRAIL signaling and function. Understanding TRAIL mechanism(s) in vivo and its involvement in disease may lead to novel strategies to combat the growing pandemic of obesity and diabetes worldwide. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  TRAIL; apoptosis; diabetes; non-apoptotic signaling; obesity

Mesh:

Substances:

Year:  2013        PMID: 23948591     DOI: 10.1016/j.tem.2013.07.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  20 in total

Review 1.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

2.  IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis.

Authors:  Amanda A Watkins; Kei Yasuda; Gabriella E Wilson; Tamar Aprahamian; Yao Xie; Elena Maganto-Garcia; Prachi Shukla; Lillian Oberlander; Bari Laskow; Hanni Menn-Josephy; Yuanyuan Wu; Pierre Duffau; Susan K Fried; Andrew H Lichtman; Ramon G Bonegio; Ian R Rifkin
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

3.  Expression-based Genome-wide Association Study Links OPN and IL1-RA With Newly Diagnosed Type 1 Diabetes in Children.

Authors:  Xiaofan Jia; Kyoko Toda; Ling He; Dongmei Miao; Satoru Yamada; Liping Yu; Keiichi Kodama
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

Review 4.  Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer.

Authors:  Ufuk Mert; Ahter Dilsad Sanlioglu
Journal:  Cell Mol Life Sci       Date:  2016-08-10       Impact factor: 9.261

Review 5.  Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders.

Authors:  Isabel Moreno-Indias; Francisco José Tinahones
Journal:  J Diabetes Res       Date:  2015-04-02       Impact factor: 4.011

6.  Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.

Authors:  Meda E Pavkov; Robert G Nelson; William C Knowler; Yiling Cheng; Andrzej S Krolewski; Monika A Niewczas
Journal:  Kidney Int       Date:  2014-10-01       Impact factor: 10.612

Review 7.  TRAIL modulates the immune system and protects against the development of diabetes.

Authors:  Fleur Bossi; Stella Bernardi; Giorgio Zauli; Paola Secchiero; Bruno Fabris
Journal:  J Immunol Res       Date:  2015-02-18       Impact factor: 4.818

8.  TRAIL (TNF-related apoptosis-inducing ligand) inhibits human adipocyte differentiation via caspase-mediated downregulation of adipogenic transcription factors.

Authors:  Verena Zoller; Jan-Bernd Funcke; Michaela Keuper; Muad Abd El Hay; Klaus-Michael Debatin; Martin Wabitsch; Pamela Fischer-Posovszky
Journal:  Cell Death Dis       Date:  2016-10-13       Impact factor: 8.469

9.  Soluble TRAIL Concentration in Serum Is Elevated in People with Hypercholesterolemia.

Authors:  Wen Cheng; Fangfang Liu; Zhe Wang; Yun Zhang; Yu-Xia Zhao; Qunye Zhang; Fan Jiang
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

10.  Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms.

Authors:  Belinda Ann Di Bartolo; Siân Peta Cartland; Leonel Prado-Lourenco; Thomas Scott Griffith; Carmine Gentile; Jayant Ravindran; Nor Saadah Muhammad Azahri; Thuan Thai; Amanda Wing Shee Yeung; Shane Ross Thomas; Mary Meltem Kavurma
Journal:  J Am Heart Assoc       Date:  2015-11-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.